Does Amphastar Pharmaceuticals (AMPH) Pay a Dividend? (2026)
Last updated November 2026
Short answer
No. Amphastar Pharmaceuticals (AMPH) pays no dividend, so the yield is 0% and the position generates no income while you hold it. Its earnings position, ~$99 million, is the reason that matters most: companies typically start paying only once earnings and free cash flow are durable enough to support a standing commitment. All of AMPH's return has to come from the share price. Verify the current policy on AMPH's investor relations page.
Does Amphastar Pharmaceuticals (AMPH) pay a dividend?
No. There is no dividend on AMPH in our data and the yield is 0%. Priced at the $28.15 close on November 20, 2026, Amphastar trades near 13x trailing GAAP earnings, 8.4x forward estimates and about 8.4x EV/EBITDA. The gap between GAAP and adjusted earnings comes mainly from amortization of the BAQSIMI intangible and share-based compensation. Net debt is roughly ~$460 million, and the six analysts in the consensus rate the stock Hold on average with a mean target of ~$24.50, below the current price.
Plainly: if you are holding AMPH for income, it does not provide any. The only way a position in it puts cash in your pocket is if you sell shares.
Why AMPH pays no dividend
Amphastar Pharmaceuticals's earnings position (~$99 million) is the constraint. A dividend is a standing commitment that a board is very reluctant to cut once started, because a cut is read as a signal about the business. Companies therefore wait until profits and free cash flow are durable before starting one, and many never do, preferring buybacks, which can be paused without the same signalling cost.
Retaining cash is not a weakness in itself. A company that can reinvest a dollar at a high return creates more value by keeping it than by paying it out. The question is whether Amphastar Pharmaceuticals is actually earning that return on what it reinvests, which is a business question, not a dividend question.
What would have to change for AMPH to start paying
Consistent profitability first, then free cash flow that comfortably exceeds what the business needs to keep growing, and then a management view that it has run out of better uses for the money. Those show up in the quarterly numbers well before any announcement, so the results are the place to watch. The press releases come later. We are not predicting whether or when that happens.
Where investors get income instead
The common approach is to hold AMPH for the growth exposure and get income from somewhere else in the portfolio, so each position does one job. The income side means dividend-paying stocks, dividend ETFs, or short-term bond and Treasury funds, sized so the income side covers what you need.
- Best dividend stocks for individual payers with long records.
- Best dividend ETFs to get a spread of payers in one holding.
- Best ETFs for monthly income if the timing of the cash matters to you.
Walnut is informational and is not an investment adviser. None of these are recommendations.
Tax: what a zero-dividend stock changes
With no dividend there is no income to report while you hold AMPH, so nothing is taxable until you sell. At sale you owe capital-gains tax on the gain, at long-term rates if you held for more than a year. Compared with a dividend payer in a taxable account, which generates a tax bill every year whether you spend the cash or reinvest it, that deferral is a small structural advantage. See how stocks are taxed. This is not tax advice.
The bottom line on the AMPH dividend
There is not one. Amphastar Pharmaceuticals (AMPH) is a total-return holding: it either works through the share price or it does not work. If you own it, own it for that reason, and build the income part of your portfolio elsewhere. For the full picture see the AMPH guide. Walnut can show how AMPH fits your real portfolio. It is not an investment adviser.
Your questions about Amphastar Pharmaceuticals
Ask Walnut's AI anything about AMPH and see how it fits what you own.
FAQ
Does Amphastar Pharmaceuticals (AMPH) pay a dividend?
+
No. Amphastar Pharmaceuticals has no dividend on record, so the yield is 0% and holding AMPH produces no income. Amphastar Pharmaceuticals directs its cash back into the business, through research, capacity, acquisitions, or buybacks. Every dollar of return from AMPH has to come from the share price. Verify the current policy on AMPH's investor relations page, since a board can start a dividend at any time.
Why doesn't AMPH pay a dividend?
+
Amphastar Pharmaceuticals directs its cash back into the business, through research, capacity, acquisitions, or buybacks. Paying nothing is a deliberate choice, not a failure. A growth company that can reinvest at high returns creates more value per dollar retained than it would by handing that dollar to shareholders.
Will AMPH ever pay a dividend?
+
Nobody can say, and we will not guess. What usually has to happen first is a stretch of durable profitability and positive free cash flow, with enough left over after reinvestment that the company runs out of better uses for the money. Those show up in the quarterly results well before any announcement. Companies also often start with buybacks before a dividend, because a buyback carries no ongoing commitment.
What is AMPH's dividend yield?
+
0%. There is no dividend, so there is no yield. This matters for planning: if you are building an income portfolio, AMPH contributes nothing to the income side and its entire contribution is price return. It also means the position generates no taxable income while you hold it.
How do I get income if I own AMPH?
+
The usual approach is to pair a non-payer like AMPH with holdings that do pay: dividend stocks, dividend ETFs, or bond funds, sized so the income side of the portfolio meets your needs while the growth side stays intact. Some investors sell covered calls on positions they hold, though that caps the upside that is the whole reason to own a growth name. See our guides to the best dividend stocks and best dividend ETFs. Walnut is not an investment adviser.
Do I owe tax on AMPH if it pays no dividend?
+
Not while you hold it. With no dividend there is no income to report, so nothing is taxable until you sell. At that point you owe capital-gains tax on the gain, at long-term rates if you held for more than a year and at ordinary-income rates if you did not. That deferral is a genuine, if minor, advantage of non-payers in a taxable account. This is not tax advice.
Is AMPH a bad stock for income investors?
+
It is the wrong tool for that job, which is not the same as a bad company. If you need cash from your portfolio, a stock paying nothing forces you to sell shares to generate it, which means selling into whatever price the market happens to offer. Investors who want AMPH's growth exposure and also want income typically hold both kinds of position and give each one job.
Does Amphastar pay a dividend or buy back stock?
+
Amphastar does not pay a dividend. It returns cash through share repurchases instead, and has done so heavily. Shares outstanding fell to ~42.5 million at July 31, 2026 from roughly 47 million a year earlier, the company spent ~$74 million on buybacks in the first half of 2026, including ~$30 million in Q1, and in November 2026 the board authorized another $50 million. The 2023 convertible note offering also funded a $50 million repurchase. Buybacks lift earnings per share even when net income is flat, which helped adjusted EPS beat estimates in Q2 and Q3 2026. The tradeoff is balance-sheet flexibility, since total debt is ~$692 million against ~$231 million of cash after the $100 million BAQSIMI milestone owed to Lilly in Q3 2026.
Walnut is informational, not investment advice. Dividend figures on this page come from a November 2026 data pull and are approximate; verify the current yield, amount, schedule, and policy with AMPH's investor relations page or your broker before acting on them.